Clinical Trials Logo

Avascular Necrosis of Femur Head clinical trials

View clinical trials related to Avascular Necrosis of Femur Head.

Filter by:
  • None
  • Page 1

NCT ID: NCT01613612 Enrolling by invitation - Clinical trials for Avascular Necrosis of Femur Head

Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH)

Start date: March 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of autologous enriched bone marrow cell implantation combined with core decompression to single core decompression for the treatment of avascular necrosis of femoral head.

NCT ID: NCT01605383 Completed - Clinical trials for Avascular Necrosis of Femur Head

Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head

Start date: May 5, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The present study evaluates the effect of XCEL-MT-OSTEO-ALPHA in osteonecrosis of the femoral head in comparison to the standard treatment of isolated core decompression. XCEL-MT-OSTEO-ALPHA is a tissue engineering product composed by "ex-vivo" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue. The working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration, avoiding the progression to collapse of the femoral head.